Protein kinase C (PKC)-mediated desensitization of the corticotropin releasing factor type 1 (CRF 1 ) receptor was investigated in human retinoblastoma Y79 and transfected COS-7 cells. Because stimulation of Y79 cells with CRF resulted in large (ϳ30-fold) increases in intracellular cAMP accumulation without changing inositol phosphate levels, the CRF 1 receptor expressed in retinoblastoma cells couples to G s, but not to G q , and predominantly signals via the protein kinase A cascade. Direct activation of PKC by treatment with the phorbol ester phorbol 12-myristate 13-acetate (PMA) or 1,2-dioctanoyl-snglycerol (DOG) desensitized CRF 1 receptors in Y79 cells, reducing the maximum for CRF-(but not forskolin)-stimulated cAMP accumulation by 56.3 Ϯ 1.2% and 40.4 Ϯ 2.1%, respectively (p Ͻ 0.001). Pretreating Y79 cells with the PKC inhibitor bisindolylmaleimide I (BIM) markedly inhibited PMA's desensitizing action on CRF-stimulated cAMP accumulation, but did not affect homologous CRF 1 receptor desensitization. Retinoblastoma cells were found to express PKC␣, ␤I, ␤II, ␦, , and RACK1. When ␣ and ␤ isoforms of PKC were down-regulated 80 to 90% by a 48-h PMA exposure, PMA-induced CRF 1 receptor desensitization was abolished. In transfected COS-7 cells the magnitude of CRF 1 receptor phosphorylation after a 5-min exposure to PMA was 2.32 Ϯ 0.21-fold greater compared with the basal level. Pretreating COS-7 cells with BIM abolished PMA-induced CRF 1 receptor phosphorylation. These studies demonstrate that protein kinase C (possibly ␣ and ␤ isoforms) has an important role in the phosphorylation and heterologous desensitization of the CRF 1 receptor.
toma Y79, neuroblastoma IMR-32, and transfected fibroblast Ltk cells exposed to high agonist concentrations of CRF or urocortin1 (Dieterich et al., 1996; Hauger et al., 1997; Dautzenberg et al., 2001a Roseboom and Kalin, 2001) . Our data indicate that GRK3 plays an important role in the homologous desensitization of CRF 1 receptors. First, in Y79 cells, uptake of a GRK3 antisense oligonucleotide or transfection of a GRK3 antisense cDNA construct decreased GRK3 expression by ϳ55% and inhibited homologous CRF 1 receptor desensitization by ϳ65% (Dautzenberg et al., 2001a) . In addition, a large increase in GRK3 expression occurs in Y79 cells during the emergence of CRF-induced CRF 1 receptor desensitization . We have also observed that epitope-tagged CRF 1 receptors expressed in COS-7 cells are rapidly phosphorylated following exposure to a saturating concentration of CRF (Hauger et al., 2000) . Since COS-7 cells express GRK2, but not GRK3 (Menard et al., 1997) , it appears that GRK2 also has a role in desensitizing CRF 1 receptors. These findings suggest that GRK3, and possibly GRK2, regulate CRF 1 receptor signaling when the release of endogenous agonists in the central nervous system is increased by stress.
In contrast to homologous desensitization, heterologous mechanisms can attenuate receptor responsiveness independent of agonist binding. Typically, heterologous desensitization occurs when an unactivated receptor is phosphorylated via the catalyzing action of a specific second messenger kinase that has been stimulated by another GPCR (Penn and Benovic, 1998; Pierce et al., 2002) . Several studies have shown that protein kinase A (PKA) desensitizes many G scoupled GPCRs by phosphorylating intracellular consensus sites (Krupnick and Benovic, 1998; Penn and Benovic, 1998; Pierce et al., 2002; Kohout and Lefkowitz, 2003) . Because the agonist-induced "active" conformation of the CRF 1 receptor couples to G s , which in turn activates the cAMP-PKA pathway, it was initially predicted that PKA would have a predominant role in CRF 1 receptor desensitization (Chen et al., 1993) . However, neither maximal PKA stimulation nor PKA inhibition influenced CRF 1 receptor phosphorylation and desensitization (Hauger et al., 2000; Dautzenberg et al., 2001a; Roseboom and Kalin, 2001 ). Thus, PKA does not appear to mediate homologous or heterologous desensitization of the CRF 1 receptor.
Protein kinase C (PKC) can also mediate homologous or heterologous GPCR desensitization. PKC-mediated phosphorylation of GPCR and adenylyl cyclase proteins contributes to desensitization, internalization, and down-regulation of many receptors (Penn and Benovic, 1998; Oppermann et al., 1999; Olivares-Reyes et al., 2001; Bhattacharyya et al., 2002; Mandyam et al., 2002; Pierce et al., 2002) . PKC-mediated mechanisms have important roles in regulating ion channel sensitivity and other aspects of postsynaptic neurotransmission, including long-term potentiation and depression (Tanaka and Nishizuka, 1994) . PKC-related signaling abnormalities have also been implicated in the pathophysiology of a wide variety of human illnesses (Tanaka and Nishizuka, 1994; Dempsey et al., 2002) .
Two potential PKC phosphorylation sites (Ser 386 and Ser 408 ) are present in the cytoplasmic C-terminal tail of the CRF 1 receptor (Chen et al., 1993; Dautzenberg et al., 2001b) . A recent study has shown that oxytocin receptor activation initiates heterologous desensitization of CRF-stimulated cAMP accumulation in human myometrial cells via a PKCdependent mechanism (Grammatopoulos and Hillhouse, 1999) . Because CRF 1 receptors have been shown to couple to G q proteins and signal via the PKC cascade (Ulisse et al., 1990; Kiang et al., 1994; Dieterich et al., 1996; Karteris et al., 2000) , PKC may also contribute to homologous CRF 1 receptor phosphorylation and desensitization. The primary goal of this study was to test the hypothesis that protein kinase C mediates phosphorylation and desensitization of the CRF 1 receptor.
Materials and Methods
Materials. Reagent purchases were as follows. 1) Bovine serum albumin (BSA, fraction V), isobutylmethylxanthine, forskolin, and other highly pure chemicals: Sigma-Aldrich (St. Louis, MO); 2) aprotinin (Trasylol), phorbol 12-myristate 13-acetate (PMA), 4␣-phorbol 12-myristate 13-acetate (an inactive PMA isomer), 1,2-dioctanoyl-snglycerol (DOG), bisindolylmaleimide I (BIM), staurosporine: Calbiochem (San Diego, CA); 3) defined fetal bovine serum (SH30070.03): Hyclone Laboratories (Logan, UT). The University of California, San Diego Cell Culture Core Facility supplied all other cell culture reagents (Mediatech, Herndon, VA). Ovine CRF (CRF: Bachem California, Torrance, CA; purity Ͼ98%) was used to stimulate cAMP accumulation in all experiments and to desensitize CRF 1 receptors. All SDS-PAGE reagents were purchased from Invitrogen-Novex (Carlsbad, CA). For CRF 1 receptor phosphorylation experiments, the following reagents were used: 1) protein A-Sepharose (PrA-Seph) (Oncogene Research Products, San Diego, CA); 2) HA.11 mouse monoclonal anti-HA antibody (Babco, Richmond, CA).
Cell Culture and Transfection. Suspension human retinoblastoma Y79 cultures were grown at a density of 5 to 8 ϫ 10 7 cells/flask in RPMI 1640 and used between passages 4 and 25 as previously described (Hauger et al., 1997; Dautzenberg et al., 2001a) . COS-7 cells were seeded at 6 ϫ 10 5 cells/10-cm dish in DMEM containing 10% (v/v) fetal bovine serum, 100 g/ml streptomycin, and 100 IU/ml penicillin (COS-7 cell medium). COS-7 cells were cultured for 3 days before transfection using 5 ml of OptiMEM containing 10 g/ml LipofectAMINE (Invitrogen, Carlsbad, CA) and 5 g of HA-tagged CRF 1 receptor cDNA for 6 h at 37°C as described (Hauger et al., 2000) . After changing to fresh COS-7 cell medium, the cells were cultured for a further 2 days before use.
Second Messenger Assays. Following extensive cell washing, intracellular cAMP levels were measured in ether-extracted and acetylated cell lysates using a double-antibody radioimmunoassay kit (cAMP [ 125 I] assay system, RPA 509; Amersham Biosciences UK, Ltd., Little Chalfont, Buckinghamshire, UK), as previously described (Hauger et al., 1997; Dautzenberg et al., 2001a) . For inositol phosphate (IP) experiments, Y79 cells were metabolically labeled with myo-[2-
3 H]inositol (5 Ci/ml) overnight (18 h). After labeled cells were washed twice with a large volume (40 ml) of myoinositol-free RPMI 1640, they were preincubated in myoinositol-free Medium 199(E) with 10 mM lithium chloride for 30 min at 37°C. After cells were again washed, centrifuged, and resuspended in myoinositolfree Medium 199(E) with 10 mM lithium chloride, they were maximally stimulated with 1 M CRF for 20 min. After the reaction was stopped by adding 10 mM formic acid, formation of IP 2 and IP 3 was measured by anion exchange chromatography using Bio-Rad AG 1-X8 columns, as previously described (Olivares-Reyes et al., 2001) .
Western Blot Quantitation of PKC Protein Expression. Lysates of Y79 cells (20 -30 g per lane) were loaded onto 4 to 12% Tris-glycine gradient gels (Invitrogen-Novex) and proteins were resolved in a NOVEX Xcell II Mini-Cell System using SDS-PAGE under reducing conditions (Invitrogen-Novex Tris-glycine SDS sample buffer containing 5.0% ␤-mercaptoethanol) at a fixed 125 V (current 35-40 amps) for 90 min according to the method of Laemmli (Dautzenberg et al., 2001a; Dautzenberg and Hauger, 2001 Western transfer of resolved retinoblastoma proteins onto polyvinylidine difluoride membranes (Invitrogen-Novex) was completed (Dautzenberg et al., 2001a; Dautzenberg and Hauger, 2001) , blots were blocked for 1 h in a solution of Tris-buffered saline (20 mM Tris pH 7.5, 500 mM NaCl) with 0.2% Tween 20 and 4% BSA (TTBS-BSA) with constant shaking at room temperature. Blots were then washed with TTBS-BSA and immunoprobed overnight (ϳ18 h) at 4°C with constant shaking with one of the following antibodies: 1) a mouse monoclonal antibody targeting PKC␣ (610108; 1:1,000), PKC␥ (611158; 1:1,000), PKC␦ (610397; 1:500), PKC⑀ (610085; 1:1,000), PKC (610814; 1:250), PKC (610089; 1:250), PKC (610175; 1:250), PKC (610207; 1:250), RACK1 (610178; 1:2,500), or DGK (610930; 1:250) (BD Biosciences PharMingen Transduction Laboratory; San Diego, CA); 2) a mouse monoclonal targeting PKC␤I (E-3/sc-8049; 1:100) or a rabbit polyclonal targeting PKC␤II (C-18/sc-210; 1:200) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); or 3) a rabbit polyclonal antibody (P500; 1:3,000, kindly provided by Dr. A. Newton, Department of Pharmacology, University of California, San Diego) targeting the phosphorylated activation loop of protein kinase C␤II (Dutil and Newton, 2000) . After the membranes were washed in TTBS-BSA (six 10-min washes), blots were incubated for 1 h at room temperature with constant shaking with one of the following antibodies (in TTBS-BSA): 1) sheep anti-mouse IgG-HRP (NA931, 1:5,000; Amersham Biosciences Inc., Piscataway, NJ) or 2) donkey anti-rabbit IgG-HRP (NA934, 1:5,000; Amersham Biosciences Inc.). After membranes were washed extensively in TTBS (six 20-min washes), chemiluminescent detection of Western blots was performed using ECL ϩ Plus (Amersham Biosciences Inc.). CRF 1 Receptor Phosphorylation Assay. Phosphorylation of the CRF 1 receptor was determined as previously described (Hauger et al., 2000) . Briefly, transfected COS-7 cells in 10-cm dishes were metabolically labeled for 4 h at 37°C in 5 ml of P i -free DMEM containing 0.1% (w/v) BSA and 100 Ci/ml 32 P i . Cells were then pretreated with vehicle or BIM for 30 min followed by a 5-min exposure to PMA for 5 min. Treated cells were lysed in buffer (LB: 50 mM Tris, pH 8.0, 100 mM NaCl, 20 mM NaF, 10 mM sodium pyrophosphate, 5 mM EDTA, 10 mg/ml aprotinin, 10 g/ml leupeptin, 10 g/ml soybean trypsin inhibitor, 10 g/ml pepstatin, 10 g/ml benzamidine, 1 mM phenylmethylsulfonyl fluoride, 1 M okadaic acid) and probe-sonicated twice for 20 s. After removal of nuclei at 750g, membranes were pre-extracted by the addition of an equal volume of LB containing 2 M NaCl and 8 M urea followed by overnight tumbling at 4°C. The membranes were then collected at 200,000g and solubilized in LBϩ [LB supplemented with 1% (v/v) NP 40, 1% (w/v) sodium deoxycholate, and 0.1% (w/v) SDS] with Dounce homogenization. After clarification at 14,000g, solubilized membranes were precleared by being incubated with 2% (v/v) protein A-Sepharose for 1 h at 4°C. Immunoprecipitation of CRF 1 receptors was performed by adding 1 l of HA.11 antibody and 2% (v/v) protein A-Sepharose and incubating overnight at 4°C. After washing of the Sepharose-bound immune complexes in LBϩ lacking protease inhibitors, 32 P-labeled phospho-HA-CRF 1 receptors were eluted in Laemmli sample buffer for 1 h at 48°C and resolved by SDS-PAGE (8 -16% gradient resolving gel) before visualization in a PhosphorImager (Amersham Biosciences Inc.).
Data Reduction and Statistical Analyses. CRF 1 receptor desensitization data were calculated as percentage of control values as previously described (Hauger et al., 1997) . Data reduction for the cyclic AMP radioimmunoassay was performed using a log-logit program. Analyses of variance (ANOVAs) across experimental groups were performed on a MacIntosh PC using PRISM Version 2.0 (GraphPad Software Inc., San Diego, CA). If the one-way ANOVA was statistically significant, planned post hoc analyses were performed using Bonferroni's multiple comparison tests to determine individual group differences. Immunoreactive PKC protein bands on Western blots were quantitated and analyzed on the STORM imager using ImageQuant software (Amersham Biosciences Inc.) (Dautzenberg et al., 2001a).
Results
Time Course for PMA-Induced CRF 1 Receptor Desensitization in Y79 Cells. We began our study by investigating potential PKC regulation of CRF 1 receptor signaling in human retinoblastoma Y79 cells. Although PMA-induced PKC activation augments the ability of CRF to stimulate cAMP accumulation and adrenocorticotropin release in anterior pituitary cells (Abou-Samra et al., 1987) , the magnitude of cAMP accumulation stimulated by 100 nM CRF was decreased by ϳ50% when Y79 cells were coincubated with 100 nM PMA during the 15-min stimulation period (Fig. 1A) . When Y79 cells were stimulated with 1 M CRF for 20 min, inositol phosphate levels were not increased above basal (i.e., no CRF stimulation) values (Fig. 1B ) in contrast to a 29.5 Ϯ 0.9-fold increase in cAMP formation observed in CRF-stimulated cells (p Ͻ 0.0001; data not shown). Previous studies have shown that PKC participates in both homologous and heterologous GPCR desensitization by promoting the phosphorylation of serines and threonines within consensus sites located in a receptor's C terminus and/or other intracellular loops (Penn and Benovic, 1998; Pierce et al., 2002) . When Y79 cells were pretreated for 1 h with 1 M PMA to maximally activate PKC, the magnitude of cAMP accumulation following subsequent restimulation with 100 nM CRF was decreased by ϳ50% (p Ͻ 0.0001) (Fig. 1C) , thereby providing evidence for PKC mediation of CRF 1 receptor desensitization. When the reversibility of PMA-induced desensitization of CRF 1 receptors was investigated, we found that CRFstimulated cAMP stimulation failed to recover from the desensitized state in Y79 cells that were exposed to 1 ⌴ PMA for 1 h, washed extensively, and then cultured for an additional 4 h (data not shown). The specificity of PMA-induced CRF 1 receptor desensitization was confirmed by demonstrating that CRF-stimulated cAMP accumulation was not significantly reduced following a 1-h pretreatment with 1 M 4␣-phorbol, a PMA analog that is incapable of activating PKC (Fig. 1C) . Although Y79 cells were washed thoroughly at the end of the pretreatment period, basal cAMP levels were significantly increased (p Ͻ 0.001) following a 1-h exposure to PMA but not 4␣-phorbol (Fig. 1) .
When the time course of the desensitizing effect of PMA pretreatment was analyzed, CRF-stimulated cAMP accumulation was found to decrease progressively in Y79 cells exposed to 1 M PMA for 5 min (22.7 Ϯ 1.6%), 10 min (48.9 Ϯ 2.2%), 15 min (48.8 Ϯ 2.6%), and 30 min (58.2 Ϯ 2.6%) (Fig.  2A) . The magnitude of PMA-induced CRF 1 receptor desensitization was similar in Y79 cells exposed to PMA for 30 min or 1 h (56.3 Ϯ 1.2%) ( Fig. 2A) . However, the reduction in CRF-stimulated cAMP accumulation was significantly less following exposure to PMA for 3 h (42.2 Ϯ 1.2%; p Ͻ 0.01) compared with 1 h (Fig. 2A) . Although PMA pretreatment markedly reduced cAMP accumulation in Y79 cells rechallenged with CRF, it did not significantly decrease forskolinstimulated cAMP accumulation during the same time period (Fig. 2A) . When full CRF concentration-response curves were generated, the maximum CRF-stimulated cAMP accumulation was decreased ϳ50% in Y79 cells exposed to 1 M PMA (14.0 pmol/106 cells) compared with control cells (28.8 pmol/ 106 cells) (Fig. 2B) .
The time course for homologous CRF 1 receptor desensitization in Y79 cells exposed to 1 M CRF for 5 min to 3 h revealed progressive reductions in CRF-stimulated cAMP accumulation (p Ͻ 0.0001) (Fig. 3) . However, in contrast to the time course of PMA-induced CRF 1 receptor desensitization ( Fig. 2A) , the reduction in CRF-stimulated cAMP accumulation was significantly greater in Y79 cells exposed to 1 M CRF for 3 h (65.4 Ϯ 1.8%; p Ͻ 0.05) compared with 1 h (49.3 Ϯ 2.8%) (Fig. 3) . The stimulation of cAMP accumulation by 50 M forskolin in Y79 cells desensitized by CRF did not differ from cAMP responses to forskolin in control cells (data not shown), as previously observed (Hauger et al., 1997) . M. values of cAMP levels (n ϭ 12 per group). By ANOVA, there were significant differences across the groups for changes in cAMP levels (F ϭ 747.4, p Ͻ 0.0001). The following post hoc differences were found to be statistically significant between cell groups: a, p Ͻ 0.001 versus basal; b, p Ͻ 0.001 versus 100 nM PMA; c, p Ͻ 0.05 versus basal; d, p Ͻ 0.001 versus 100 nM CRF. B, effect of incubation with 1 M CRF on inositol phosphate generation during a 20-min stimulation period. No significant differences (F ϭ 2.52; p ϭ 0.10) in IP 2 /IP 3 levels were observed in CRF-stimulated or basal cells. C, effect of pretreatment with 1 M PMA or 1 M 4␣-phorbol for 1 h before a 15-min stimulation with 100 nM CRF. Each bar represents mean Ϯ S.E.M. values of cAMP levels (n ϭ 5 per group). Retinoblastoma CRF 1 receptors were desensitized by 46% during the 1-h exposure to PMA, but not 4␣-phorbol. By ANOVA, there were significant differences across the groups for changes in cAMP levels (F ϭ 117.7, p Ͻ 0.0001). The following post hoc differences were found to be statistically significant between cell groups: a, p Ͻ 0.001 versus basal; b, p Ͻ 0.001 versus control-CRF; c, p Ͻ 0.001 versus 4␣-phorbol-CRF; d, p Ͻ 0.001 versus control-basal or 4␣-phorbol-basal. We next established the concentration-dependence of the desensitizing effect of a 15-min PMA exposure on the ability of CRF to stimulate cAMP accumulation. CRF-stimulated cAMP accumulation was first observed to decrease at 10 nM PMA (80.8 Ϯ 2.0% control; p Ͻ 0.001) and reached a nadir at 100 nM PMA (48.1 Ϯ 3.6% control; p Ͻ 0.001) (Fig. 4) . The EC 50 values for the PMA-induced CRF 1 receptor desensitization data were 15 nM. When Y79 cells were coincubated for 15 min with 10 nM CRF (which alone did not significantly desensitize CRF 1 receptors) and 10 nM PMA, the magnitude of CRF 1 receptor desensitization (48.3 Ϯ 2.6%; p Ͻ 0.05) was significantly greater than that caused by 15-min pretreatment with 10 nM PMA (32.8 Ϯ 3.7%) (Fig. 5) . Concentrationdependent CRF 1 receptor desensitization was also observed in Y79 cells exposed to PMA (0 -1 M) for 1 h (p Ͻ 0.0001; data not shown).
Effect of 1,2-Dioctanoyl-sn-glycerol (DOG) on CRFStimulated cAMP Accumulation. DOG structurally resembles the diacylglycerols formed when membrane phosphoinositides are hydrolyzed during G q -coupled GPCR activation, and represents a more "physiological" signal stimulating PKC translocation to the membrane. (Fig. 6) . The magnitude of CRF 1 receptor desensitization resulting from a 1-h DOG exposure (40.4 Ϯ 2.1%; p Ͻ 0.05) was significantly greater than that observed after a 3-h DOG exposure (29.0 Ϯ 2.7% decrease) (Fig. 6) .
Expression of Protein Kinase C Isoforms in Y79 Cells. Retinoblastoma cell lysates were immunoprobed with antibodies that selectively recognize specific PKC isoforms to of values expressed as percentage of control (n ϭ 10 replicates per treatment group). These data were replicated in two independent experiments. By ANOVA, there were significant differences across the groups (F ϭ 51.99, p Ͻ 0.0001). The following post hoc differences were found to be statistically significant between groups: a, p Ͻ 0.001 versus control; b, p Ͻ 0.001 versus 10 nM CRF 15 min; c, p Ͻ 0.05 versus 10 nM PMA 15 min. (Fig. 7A) , PKC␤I (Fig. 7 , B and C), and PKC (Fig. 7D) . Expression of PKC␤II, PKC␦, PKC ((the mouse homolog of PKC), and RACK1 (a receptor protein that anchors protein kinase C to the membrane) was also detected in Y79 cells (data not shown). However, no immunoreactive bands were detected with specific antibodies for PKC␥, PKC⑀, PKC, PKC, and DGK (data not shown). When additional immunoblotting experiments were performed using a polyclonal phospho-specific antibody (P500) targeting the phosphorylated activation loop of all PKC isoforms (Dutil and Newton, 2000) , several bands migrating to 75-80 kDa were detected in Y79 cells (data not shown). Consequently, phosphorylated "mature" PKC species are present in the retinoblastoma cytosol. Only PKC isoforms with a phosphorylated activation loop are capable of catalyzing PKC-mediated phosphorylation of cellular proteins (Dutil and Newton, 2000) .
The levels of PKC␣ and ␤I proteins were depleted in Y79 cells exposed to PMA for 24 h or 48 h compared with control cells (Fig. 7, A-C) . In contrast, incubating Y79 cells with 1 M CRF for 24 h or 48 h did not decrease the expression of PKC␣ (data not shown) or PKC␤I (Fig. 7C ). This duration of CRF treatment produces Ͼ90% desensitization of retinoblastoma CRF 1 receptors and a 2-to 3-fold up-regulation of GRK3 expression (Hauger et al., 1997; .
Effect of Down-Regulating PKC Expression on PMAInduced CRF 1 Receptor Desensitization. Down-regulation of PKC by chronic phorbol ester treatment is another method for confirming that protein kinase C plays a role in receptor desensitization. Prolonged exposure of cells to PMA induces proteolysis, thereby depleting classical and novel, but not atypical, isoforms of PKC (Tanaka and Nishizuka, 1994) . When retinoblastoma cells were pretreated with 1 M PMA for 1 h, the magnitude of CRF-stimulated cAMP accumulation (11.4 Ϯ 0.3 pmol/10 6 cells; p Ͻ 0.001) again decreased by 60% compared with the CRF-stimulated cAMP response in control cells (Fig. 8) . However, a large decrement in the ability of PMA to desensitize CRF 1 receptors was observed in Y79 cells chronically exposed to 1 M PMA for 24 h (61.8 Ϯ 4.9% of control) before 1-h PMA pretreatment and subsequent 15-min CRF stimulation (Fig. 8A) . The similar magnitudes of CRF-stimulated cAMP accumulation in control Y79 cells (20.1 Ϯ 0.6 pmol/10 6 cells) and cells subjected to the 48-h PMA exposure (22.0 Ϯ 0.5 pmol/10 6 cells) indicated that chronic PMA treatment abolished PMA-induced CRF 1 receptor desensitization (Fig. 8A) . Exposure of Y79 cells to PMA for 1 h, 24 h, or 48 h did not alter forskolinstimulated cAMP accumulation (Fig. 8, A and B) . As described above, the levels of PKC␣, ␤I, and ␤II proteins were depleted in Y79 cells exposed to PMA for 24 h or 48 h compared with control cells, while PKC expression did not change (Fig. 7, A-C) . Since PKC down-regulation by 48-h PMA treatment abolished PMA-induced CRF 1 receptor desensitization, typical but not atypical PKC isoforms desensitize retinoblastoma CRF 1 receptors without altering adenylyl cyclase activity. Finally, in preliminary experiments, the magnitudes of homologous CRF 1 receptor desensitization did not differ in control Y79 cells and cells in which PKC was down-regulated by 48-h PMA exposure (data not shown). (Fig. 9A ) and staurosporine (500 nM; data not shown) had no effect on the homologous desensitization of retinoblastoma CRF 1 receptors. A 15-min exposure to 100 nM CRF resulted in similar reductions in the magnitude of cAMP accumulation following subsequent restimulation with 100 nM CRF in Y79 cells pretreated for 30 min with vehicle (30.2 Ϯ 2.3%) or 2 M BIM (36.9 Ϯ 1.8%) (Fig. 9A) . In contrast, pretreating Y79 cells with BIM significantly inhibited PMA-induced CRF 1 receptor desensitization (Fig. 9B) . CRF-stimulated cAMP accumulation decreased in Y79 cells A, data (mean Ϯ S.E.M.) expressed as percentage of control for the stimulation of cAMP accumulation by 100 nM CRF (n ϭ 6 -16 per group) were collected in three independent experiments. By ANOVA, there were significant differences across the groups (F ϭ 52.5, p Ͻ 0.0001). The following post hoc differences were found to be statistically significant between groups: a, p Ͻ 0.001 versus control; b, p Ͻ 0.01 versus PMA 24 h; c, p Ͻ 0.001 versus PMA 48 h; d, p Ͻ 0.001 versus PMA 24 h-forskolin. B, representative experiment for 48-h PMA exposure. Data are mean Ϯ S.E.M. of basal and CRFand forskolin-stimulated cAMP levels (pmol/10 6 cells) (n ϭ 6 per group). By ANOVA, there were significant differences across the groups (F ϭ 288.4, p Ͻ 0.0001). Significant cAMP responses to 100 nM CRF (p Ͻ 0.001) and 50 M forskolin (p Ͻ 0.001) were observed in control cells and cells pretreated with PMA for 1, 24, and 48 h. In addition, forskolin-stimulated cAMP accumulation was significantly greater than CRF-stimulated cAMP accumulation in control and PMA-treated cells (p Ͻ 0.001). However, the 48-h PMA exposure abolished PMA-induced CRF 1 receptor desensitization. The following post hoc differences were also found to be statistically significant between groups: a, p Ͻ 0.001 versus control; b, p Ͻ 0.001 versus PMA 48 h. subjected to a 15-min exposure to 100 nM (53.9 Ϯ 1.5% of control; p Ͻ 0.001) or 1 M PMA (44.1 Ϯ 2.6% of control; p Ͻ 0.001) (Fig. 9B) . A 30-min pretreatment with 2 M BIM inhibited CRF 1 receptor desensitization 56.6 Ϯ 2.2% (p Ͻ 0.001) and 53.5 Ϯ 2.5% (p Ͻ 0.001) during a 15-min exposure to 100 nM or 1 M PMA, respectively (Fig. 9B) .
Effect of Protein Kinase C Inhibition on PMA-Induced CRF 1 Receptor Phosphorylation. We have previously reported that a high degree of CRF 1 receptor phosphorylation develops when COS-7 cells transiently transfected with an HA-epitope-tagged CRF 1 receptor cDNA are treated with CRF (Hauger et al., 2000) . A 1.82 Ϯ 0.09-fold increase (p Ͻ 0.001) in the density of the CRF 1 receptor phosphoprotein band (M r ϳ70,000) was again observed in transfected COS-7 cells stimulated for 5 min with 1 M CRF compared with the basal phosphorylation level (data not shown). PMAinduced PKC activation in transfected COS-7 cells strongly phosphorylated the CRF 1 receptor (Fig. 10A) . In a total of three experiments, the magnitude of CRF 1 receptor phosphorylation after a 5-min exposure to 200 nM PMA was 2.32 Ϯ 0.21-fold greater compared with basal phosphorylation in control cells not exposed to PMA (p Ͻ 0.001) (Fig.  10B) . A 30-min pretreatment with 2 M BIM completely abolished PMA-induced CRF 1 receptor phosphorylation (Fig.  10 ). In addition, the basal level of CRF 1 receptor phosphorylation in untreated control cells was significantly decreased by BIM pretreatment (p Ͻ 0.05; Fig. 10B ).
Discussion
This study establishes that CRF 1 receptors endogenously expressed in human retinoblastoma Y79 cells undergo rapid PKC-mediated desensitization. In a series of experiments, PMA (0 -1 M) desensitized retinoblastoma CRF 1 receptors in a time-and concentration-dependent manner during a 5-min to 1-h pretreatment period. In addition, coincubation of Y79 cells for 15 min with 10 nM PMA (i.e., a concentration producing ϳ20% desensitization) and 10 nM CRF (which did not result in any significant desensitization) before the 15-min CRF stimulation period desensitized CRF 1 receptors in an additive manner. Since forskolin-stimulated cAMP accumulation did not decrease when Y79 cells were exposed to PMA, PKC-induced CRF 1 receptor desensitization does not appear to involve a direct action of protein kinase C on adenylyl cyclase activity. When full CRF stimulation doseresponse curves were generated, the maximum for CRFstimulated cAMP accumulation decreased by more than 50% in Y79 cells exposed to 1 M PMA for 1 h. The inability of 4␣-phorbol, which cannot activate PKC, to desensitize retinoblastoma CRF 1 receptors during a 1-h pretreatment period confirmed the specificity of PMA-induced CRF 1 receptor desensitization. Pretreatment of Y79 cells for 30 min or 1 h with DOG, a more "physiological" PKC activator, also caused a large degree of CRF 1 receptor desensitization.
Protein kinase C isoforms comprise a family of serine/ threonine kinases that phosphorylate many cellular proteins, including GPCRs (Tanaka and Nishizuka, 1994; Penn and Benovic, 1998; Dempsey et al., 2002; Pierce et al., 2002) . Retinoblastoma cells were found to express three conventional PKCs (␣, ␤I, ␤II), RACK1, which selectively binds PKC␤II (Dempsey et al., 2002) , and one atypical PKC (). Diacylglycerols and phorbol esters bind to the N-terminal C1 regulatory domain of PKC␣, ␤I, and ␤II (but not PKC) and down-regulate these conventional PKC proteins when cells are chronically exposed to PKC activators (Tanaka and Nishizuka, 1994) . When the duration of PMA or DOG exposure was extended to 3 h in our study, the magnitude of CRF 1 receptor desensitization was significantly less than that occurring with a 1-h pretreatment, presumably due to in- jpet.aspetjournals.org creased proteolytic degradation of PKC proteins. Subsequent experiments confirmed this possibility by demonstrating that PMA-induced CRF 1 receptor desensitization was abolished in Y79 cells where PKC␣ and PKC␤I protein levels were depleted by a 48-h PMA exposure. PKC protein levels were not reduced in Y79 cells chronically exposed to PMA. Chronic PMA treatment can also down-regulate expression of the novel isoform PKC␦ (Tanaka and Nishizuka, 1994) , which is expressed in Y79 cells. Therefore, our data indicate that ␣-, ␤-, and possibly ␦-isoforms of PKC desensitize retinoblastoma CRF 1 receptors.
BIM acts as a competitive inhibitor at the ATP binding site within the catalytic domains of many PKC isoforms including PKC␣, PKC␤, PKC␦, PKC⑀, and PKC (Tanaka and Nishizuka, 1994) . Although 2 M BIM pretreatment did not alter homologous CRF 1 receptor desensitization, it markedly inhibited PMA-induced CRF 1 receptor desensitization. This suggests that a PKC-dependent mechanism contributes to heterologous, but not homologous, desensitization of CRF 1 receptors.
CRF 1 receptors in brain and transfected mouse fibroblast cells can couple to both G s and G q proteins, thereby activating both cAMP and phospholipase C pathways (Dieterich et al., 1996; Hillhouse et al., 2002) . In Leydig cells and placenta, CRF 1 receptors may signal via G q -mediated stimulation of phospholipase C and formation of IPs without generating an intracellular cAMP-dependent signal (Ulisse et al., 1990; Karteris et al., 2000) . Taken together, these findings suggest that the CRF 1 receptor can couple to G q and signal via the protein kinase C cascade in certain cell types (Kiang et al., 1994; . However, inositol phosphate generation was not increased in Y79 cells stimulated with CRF and inhibition of PKC in Y79 cells by BIM pretreatment failed to block homologous CRF 1 receptor desensitization. Thus, it seems likely that the CRF 1 receptor expressed in retinoblastoma cells couples to G s but not to G q . Similar findings have been observed for the pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC 1 ). The PAC 1 receptor exclusively couples to G s in Y79 cells (Olianas et al., 1996; Dautzenberg et al., 1999) , while the PAC 1 receptor couples to G s and G q in other cells (Harmar et al., 1998) .
We determined whether an HA-epitope-tagged CRF 1 receptor recombinantly expressed in COS-7 cells could be phosphorylated by protein kinase C to establish a possible mechanism for PMA-induced CRF 1 receptor desensitization. A high degree of CRF 1 receptor phosphorylation was detected in transfected COS-7 cells during a 5-min exposure to PMA-an effect that was completely abolished by 30-min pretreatment with BIM. We previously observed that CRF exposure, but not forskolin-induced PKA activation or ionomycin-induced stimulation of Ca 2ϩ /calmodulin-dependent kinases, causes phosphorylation of the CRF 1 receptor in COS-7 cells, presumably due to a G protein receptor kinase mechanism (Hauger et al., 2000) . Similarly, stimulation of PKA activity by forskolin or dibutyryl cAMP failed to desensitize CRF 1 receptors in Y79 and IMR-32 cells (Dautzenberg et al., 2001a; Roseboom and Kalin, 2001) .
Recently, mice with a targeted deletion of the PKC␤ gene were found to exhibit a deficit in fear conditioning (Weeber et al., 2000) . In BALB/c mice, context-dependent fear conditioning was augmented by injecting CRF or activating PKC in the hippocampus, while pretreatment with a PKC inhibitor impaired acute stress-induced enhancement of context-dependent fear conditioning (Blank et al., 2002 (Blank et al., , 2003 . PKC inhibitors also block CRF-induced increases in firing rates of hippocampal neurons in BALB/c mice (Blank et al., 2003) . Consequently, PKC-mediated CRF 1 receptor signaling may contribute to the expression of contextual fear. We have previously hypothesized that deficient GRK-mediated CRF 1 receptor desensitization may trigger long-term psychopathology by increasing the sensitivity of and/or prolonging agoniststimulated CRF 1 receptor signaling in brain pathways mediating fear and anxiety . The present data suggest that abnormalities in PKC-mediated phosphorylation and desensitization of CRF 1 receptors may also result in CRF 1 receptor supersensitivity and sensitization of brain CRF neurotransmission, thereby reducing the activation threshold and increasing the magnitude and duration of fear and anxiety responses.
In conclusion, we have demonstrated that rapid desensitization of retinoblastoma CRF 1 receptors occurred when protein kinase C is activated. The presence of two potential PKC phosphorylation sites (Ser 386 and Ser 408 ) in the C-terminal cytoplasmic tail of the CRF 1 receptor suggests that the phosphorylation of the CRF 1 receptor by protein kinase C observed in this study may mediate this desensitization process (Chen et al., 1993; Dautzenberg et al., 2001b) . However, depending on the cellular background, PKC-mediated CRF 1 receptor desensitization may occur via heterologous crosstalk with one or more G q -coupled GPCRs or via a homologous mechanism whereby the agonist-activated CRF 1 receptor couples to the G q protein and subsequently activates its phosphorylation by PKC. In a recent study it was found that activation of oxytocin receptors causes heterologous desensitization of CRF-stimulated cAMP accumulation in human myometrial cells via a PKC-dependent mechanism (Grammatopoulos and Hillhouse, 1999) . Based on previous reports of cross-talk between receptor signaling pathways (Selbie and Hill, 1998; Budd et al., 1999; Thakker and Standifer, 2002) , activation of heterologous GPCRs may result in crossphosphorylation, desensitization, and possibly internalization of CRF 1 receptors, thereby shifting the stress response to other receptor mechanisms. Future studies will be directed at the identification of GPCRs that desensitize retinoblastoma CRF 1 receptors via PKC-mediated cross-talk.
